Insulin resistance and blood pressure circadian variation in an obese hypertensive population

Clinical and Experimental Hypertension

Volumn 28, Issue 7, 2006, Pages 625-630

  Diamantopoulos, Emmanuel J ^a,c   Andreadis, Emmanuel ^a   Tsourous, George ^a   Katsanou, Panagiota ^a   Georgiopoulos, Dimitrios ^a   Fotia, Maria ^a   Antoniou, Athanasios ^a   Raptis, Sotirios A ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Ambulatory blood pressure; Arterial hypertension; Insulin resistance

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GENDER; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; HOMEOSTASIS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY;

EID: 33750091059     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960600946106     Document Type: Article

References (12)

1. Paoliso G, Galderisi M, Taglimonte MR, et al. Myocardial wall thickness and left ventricular geometry in hypertensives: relationship with insulin. Am J Hypertens. 1997;10:1250-1256.
2. Zavaroni I, Mazza S, Dall'Aglio E, et al. Prevalence of hyperinsulinemia in patients with high blood pressure. J Int Med. 1992;31:1128-1130.
3. Ohkubo T. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997;15:357-364.
4. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
5. Sowers JR, Frohlich ED. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Medical Clinics of North America 2004;88:63-82.
6. Chobanian AV, Bakris GL, Black H, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
7. Matthews DR, Hosker JD, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1989;28:412-419.
8. Association for the Advancement of Medical Instrumentation. American National Standards for Electronic and Automated Sphygmomanometers. Washington, DC: AAMI, 1987.
9. Anan F, Takahashi N, Ooie T, et al. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res. 2003;26:669-676.
10. DeFrozo RA, Tobin JD, Andres R. Glucose clamp technique: a method for the quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
11. Katsuki A, Sumida Y, Gabazza EC, et al. Homeostasis model assessment in a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001;24:362-365.
12. Chen JW, Jen SL, Lee WL, et al. Differential glucose tolerance in dipper and non dipper essential hypertension: the implications of circadian blood pressure regulation on glucose tolerance in hypertension. Diabetes Care 1998;21:1743-1748.